BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33920869)

  • 21. Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia.
    Jasani R; Ahmad Z; Schneider R; Tujardon C; Basit M; Khera A
    J Clin Lipidol; 2022; 16(4):508-515. PubMed ID: 35568683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
    Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
    Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
    Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
    Ramli AS; Qureshi N; Abdul-Hamid H; Kamal A; Kanchau JD; Shahuri NS; Akyea RK; Silva L; Condon L; Abdul-Razak S; Al-Khateeb A; Chua YA; Mohamed-Yassin MS; Baharudin N; Badlishah-Sham SF; Abdul Aziz AF; Mohd Kasim NA; Sheikh Abdul Kadir SH; Kai J; Leonardi-Bee J; Nawawi H
    JMIR Res Protoc; 2023 Jun; 12():e47911. PubMed ID: 37137823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
    Chan DC; Pang J; Hooper AJ; Bell DA; Burnett JR; Watts GF
    Clin Chem; 2019 Oct; 65(10):1258-1266. PubMed ID: 31307996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of heterozygous familial hypercholesterolaemia with
    Abdul-Halim MAZ; Abdul-Hamid H; Baharudin N; Mohamed-Yassin MS; Kasim SS; Nawawi H; Qureshi N; Ramli AS
    Eur Heart J Case Rep; 2024 Feb; 8(2):ytae039. PubMed ID: 38425725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.
    Futema M; Whittall RA; Kiley A; Steel LK; Cooper JA; Badmus E; Leigh SE; Karpe F; Neil HA; ; Humphries SE
    Atherosclerosis; 2013 Jul; 229(1):161-8. PubMed ID: 23669246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing familial hypercholesterolaemia (FH) screening in primary care: an updated systematic review of systematic screening methods for identificaton of FH.
    Ayoub A; Akyea RK; Silva L; Qureshi N; Molokhia M
    Br J Gen Pract; 2024 Jun; 74(suppl 1):. PubMed ID: 38902081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
    Iyen B; Qureshi N; Kai J; Akyea RK; Leonardi-Bee J; Roderick P; Humphries SE; Weng S
    Atherosclerosis; 2019 Aug; 287():8-15. PubMed ID: 31181417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can patients be accurately assessed for familial hypercholesterolaemia in primary care?
    Bell DA; Kirke AB; Barbour R; Southwell L; Pang J; Burrows S; Watts GF
    Heart Lung Circ; 2014 Dec; 23(12):1153-7. PubMed ID: 25065543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey.
    Banach M; Mazidi M; Mikhailidis DP; Toth PP; Jozwiak J; Rysz J; Watts GF
    Eur Heart J; 2018 Oct; 39(40):3635-3640. PubMed ID: 30165413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.
    Brown EE; Byrne KH; Davis DM; McClellan R; Leucker T; Jones SR; Martin SS
    J Clin Lipidol; 2020; 14(3):331-338. PubMed ID: 32220565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia.
    Clarke RE; Padayachee ST; Preston R; McMahon Z; Gordon M; Graham C; Crook MA; Wierzbicki AS
    Heart; 2013 Feb; 99(3):175-80. PubMed ID: 23213176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.
    Qureshi N; Woods B; Neves de Faria R; Saramago Goncalves P; Cox E; Leonardi Bee J; Condon L; Weng S; Akyea RK; Iyen B; Roderick P; Humphries SE; Rowlands W; Watson M; Haralambos K; Kenny R; Datta D; Miedzybrodzka Z; Byrne C; Kai J
    Health Technol Assess; 2023 Oct; 27(16):1-140. PubMed ID: 37924278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-finding and genetic testing for familial hypercholesterolaemia in primary care.
    Qureshi N; Akyea RK; Dutton B; Humphries SE; Abdul Hamid H; Condon L; Weng SF; Kai J;
    Heart; 2021 Dec; 107(24):1956-1961. PubMed ID: 34521694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.